Captan: Target Organs and Levels of Evidence for TR-015
Bioassay of Captan for Possible Carcinogenicity (CASRN 133-06-2)
| Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|
| Captan 133-06-2 |
07/25/1977 | Dosed-Feed R: 0,2525,6050 (AVG), M: 0,8000,16000 PPM/50 PER GROUP |
Gulf South Research Institute |
Levels of Evidence
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|
Female Mice: Positive
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|